| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| Company: Pfizer |
| Recipient: You |
| Company: Astra Zeneca |
| Recipient: You |
| Company: Eli Lilly |
| Recipient: You |
| Company: Exact Sciences |
| Recipient: You |
| Company: Focus Patient |
| Recipient: You |
| Company: Gilead Sciences |
| Recipient: You |
| Company: MSD |
| Recipient: You |
| Company: Novartis |
| Recipient: You |
| Company: Pfizer |
| Recipient: You |
| Company: Roche |
| Recipient: You |
| Company: Seattle Genetics |
| Recipient: You |
| Company: Pfizer |
| Recipient: Your Institution |
| Company: Pfizer |
| Recipient: Your Institution |
| Company: Lilly |
| Recipient: Your Institution |
| Company: Lilly |
| Recipient: Your Institution |
| Company: Roche |
| Recipient: Your Institution |
| Company: Novartis |
| Recipient: Your Institution |
| Company: Mundi Pharma |
| Recipient: Your Institution |
| Company: Novartis |
| Recipient: Your Institution |
| Company: Gilead Sciences |
| Recipient: Your Institution |
| Company: Seagen |
| Recipient: Your Institution |
| Company: MSD |
| Recipient: Your Institution |
|
| Consulting or Advisory Role |
| Company: Novartis |
| Recipient: You |
| Company: Novartis |
| Recipient: You |
| Company: Novartis |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: Lilly |
| Recipient: You |
| Company: Exact Sciences |
| Recipient: You |
| Company: Gilead Sciences |
| Recipient: You |
| Company: Novartis |
| Recipient: You |
| Company: Pfizer |
| Recipient: You |
| Company: Roche |
| Recipient: You |
| Company: Seattle Genetics |
| Recipient: You |
| Company: Novartis |
| Recipient: You |
| Company: Sanofi |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: Your Institution |
| Company: Lilly |
| Recipient: Your Institution |
| Company: Lilly |
| Recipient: Your Institution |
| Company: Novartis |
| Recipient: Your Institution |
| Company: Novartis |
| Recipient: Your Institution |
| Company: Novartis |
| Recipient: Your Institution |
| Company: Pierre Fabre |
| Recipient: Your Institution |
| Company: Roche |
| Recipient: Your Institution |
| Company: Roche |
| Recipient: Your Institution |
| Company: Vifor Pharma |
| Recipient: Your Institution |
| Company: Teva |
| Recipient: Your Institution |
| Company: Roche |
| Recipient: Your Institution |
| Company: MSD |
| Recipient: Your Institution |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Sanofi |
| Recipient: Your Institution |
| Company: MSD |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| Company: Novartis |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: PharmaMar |
| Recipient: You |
| Company: Pfizer |
| Recipient: You |
| Company: Roche |
| Recipient: You |
| Company: Roche |
| Recipient: You |
| Company: Roche |
| Recipient: You |
| Company: Roche |
| Recipient: You |
|
| Other Relationship |
| Company: Need Inc |
| Recipient: You |
|
| (OPTIONAL) Uncompensated Relationships |
| not answered |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|